Anat Shriki

Medicine · Health Sciences

7h-index575citations16works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(8), Cytokine Signaling Pathways and Interactions(7), Fibroblast Growth Factor Research(5), Liver physiology and pathology(3), Inflammasome and immune disorders(2)

Publications16 total

Supplementary Data from Multiple Roles of IL6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis
2023Open Access
Data from Multiple Roles of IL6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis
2023Open Access
Supplementary Data from Multiple Roles of IL6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis
2023Open Access
Data from Multiple Roles of IL6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis
2023Open Access
Supplementary Materials and Methods from Multiple Roles of IL6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis
2023Open Access
Supplementary Materials and Methods from Multiple Roles of IL6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis
2023Open Access
Multiple Roles of IL6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis
Cancer Research·2021· 30 citedOpen Access
PS-046-Suppression of complex protumorigenic phenotypes in chronic injury-associated hepatocarcinogenesis is dependent on IL-6/STAT3 signaling
Journal of Hepatology·2019
IL6-dependent genomic instability heralds accelerated carcinogenesis following liver regeneration on a background of chronic hepatitis
Journal of Hepatology·2017· 4 cited
Interleukin 6–dependent genomic instability heralds accelerated carcinogenesis following liver regeneration on a background of chronic hepatitis
Hepatology·2016· 28 cited
P0245 : The IL-6/SIL6R and STAT3 axis is crucial for hepatoprotection and suppression of liver cancer in female mice with chronic liver injury
Journal of Hepatology·2015
<i>In vivo</i> evidence suggesting reciprocal renal hypoxia‐inducible factor‐1 upregulation and signal transducer and activator of transcription 3 activation in response to hypoxic and non‐hypoxic stimuli
Clinical and Experimental Pharmacology and Physiology·2013· 19 cited
Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis
Clinical & Translational Oncology·2012· 46 cited
Early hepatocyte DNA synthetic response posthepatectomy is modulated by IL-6 trans-signaling and PI3K/AKT activation
Journal of Hepatology·2010· 41 cited
IL-6/IL-6R Axis Plays a Critical Role in Acute Kidney Injury
Journal of the American Society of Nephrology·2008· 384 citedOpen Access
JX401, A p38α Inhibitor Containing a 4-Benzylpiperidine Motif, Identified via a Novel Screening System in Yeast
Molecular Pharmacology·2006· 23 cited

Frequent Co-authors

Jonathan H. Axelrod(15), Stefan Rose‐John(14), Eithan Galun(14), Amir Sonnenblick(12), Tali Lanton(11), Rinat Abramovitch(11), Amnon Peled(11), Orit Pappo(10), Nofar Rosenberg(9), Sharona Elgavish(8), Orr Levkovitch‐Siany(7), Dana Eidelshtein(7), Yuval Nevo(7), Rifaat Safadi(7), Yael Nechemia‐Arbely(5), Orr Levkovitch(3), Revital Adar(2), Mor Paldor(2), Daniel Goldenberg(2), Daniel Barkan(1)